Studies on the Efficiency of Vitamin K₁ in Small Doses as Antidote Against Anticoagulants of the Dicoumarol Type

References

• Aas K. Prokonvertin og konvertin. Diss, Oslo 1952; 90, 29
   Google Scholar
• Andersen Harrestrup A. Et dødsfald efter dikumarolbehandling i praksis. Ugeskr. f. læger 1953; 115: 1621
   PubMedGoogle Scholar
• Bannon W. G., Owen C. A., Jr., Barker N. W. The comparative effects of menadione sodium bisulfite and vitamin K1 on the hypoprothrom-binemia induced by dicoumarol. J. Lab. & Clin. Med. 1953; 41: 393
   PubMed Web of Science ®Google Scholar
• Barker N. W., Hanson H. H., Mann F. D. Bishydroxycoumarin, ethyl bis-coumacetate, and 4-hydroxycoumarin anticoagulant No. 63. J.A. M.A. 1952; 148: 274
   PubMed Web of Science ®Google Scholar
• Bjerkelund C. J. The effect of phenylindanedione on plasma prothrombin and factor V levels and a comparison with the effect of dicumarol. Scandinav. J. Clin. & Lab. Investigation 1950; 2: 83
   PubMed Web of Science ®Google Scholar
• Brown K. W. G., MacMillan R. L. The anticoagulant effect of phenylindanedione in thromboembolic disorders. Am. J. M. Sc. 1953; 225: 495
   Web of Science ®Google Scholar
• Cromer H. E., Barker N. W. The effect of large doses of menadione bisulfite (synthetic vitamin K) on excessive hypoprothrombinemia induced by dicoumarol. Proc. Staff Meet., Mayo Clin. 1944; 19: 217
   Google Scholar
• Dam H., Søndergaard E. Comparison of the action of vitamin K1, menadione and synkavit administered intravenously to vitamin K deficient chicks. Acta pharmacol. et toxicol. 1953; 9: 131, (a)
   PubMedGoogle Scholar
• Dam H., Søndergaard E. Comparison of the anticoagulant action of 3 -(α-p - ohlorphenyl -β -acetylethyl) - 4-hydroxy-coumarin (Coumachlor) and dicoumarol in chicks and rats. Acta pharmacol. et toxicol. 1953; 9: 137, (b)
   PubMedGoogle Scholar
• Dam H., Prange I., Søndergaard E. Levels of vitamin K1 in blood and various organs of chicks and rats after the administration of massive doses. Acta pharmacol. et toxicol. 1954; 10: 58
   PubMedGoogle Scholar
• Davidson C. S., MacDonald H. The effect of vitamin K1 oxide on hypoprothrombinemia induced by dicoumarol. New England J. Med. 1943; 229: 353
   Google Scholar
• Douglas A. S., Brown A. Effect of vitamin K preparations on hypoprothrombinemia induced by dicoumarol and tromexan. Brit. M. J. 1952; I: 412
   Web of Science ®Google Scholar
• Guttas C. G., Moloney W. C., Sise H. S. Studies on the anticoagulant phenylindanedione. I. The effect of emulsified vitamin K1 on phenylindanedione-induced hypoprothromlbine-mia. Blood 1953; 8: 276
   PubMed Web of Science ®Google Scholar
• Hilden T., Munck O. Vitamin K as antagonist to anticoagulants. Scandinav. J. Clin. & Lab. Investigation 1953; 5: 361
   PubMed Web of Science ®Google Scholar
• Holten C. Anticoagulants in the treatment of coronary thrombosis. Acta med. Scandinav. 1951; 140: 340
   PubMedGoogle Scholar
• James D. F., Bennett I. L., Scheinberg P., Butler J. J. Clinical studies on dicoumarol hypoprothrombinemia and vitamin K preparations. I. Superiority of vitamin K1 oxide over menadione sodium bisulfite U. S. P. and synkayvite in reversing dicumarol hypoprothrombinemia. Arch. Int. Med. 1949; 83: 632
   Google Scholar
• James D. F., Johnson T. D., Burnett S. Treatment of dicumarol-induced hemorrhage with vitamin K1 oxide. Am. J. Med. 1951; 11: 244
   Web of Science ®Google Scholar
• Jüngens R. Experimentelle Untersuchungen über das Antikoagulans Marcumar [3-(1'-Phenyl-propyl)-4-oxy-cumarin] und seinen Antagoni-sten Konakion (synthetisches Vitamin K1). Schweiz. med. Wchnschr. 1953; 83: 471
   PubMedGoogle Scholar
• Roller F., Jakob H. Über ein neues, hoch-aktives Antikoagulans mit protrahierter Wirk-ung (Marcumar). Schweiz. med. Wchnschr. 1953; 83: 476
   PubMedGoogle Scholar
• Roller F., Loeliger A., Ducker F. Le facteur VII. Sa fonction dans la coagulation. Son importance clinique. Rev. d'hémat. 1952; 7: 156
   PubMedGoogle Scholar
• Miller R., Harvey W. P., Finch C. A. Antagonism of dicumarol by vitamin K preparations. New England J. Med. 1950; 242: 211
   PubMed Web of Science ®Google Scholar
• Overman R. S., Sorenson C. W., Wright I. S. Effectiveness of synthetic water-soluble vitamin K preparations in bishydroxycoumarin-induced hypoprothrombinemia. J.A.M.A. 1951; 145: 393
   PubMed Web of Science ®Google Scholar
• Owren P., Aas K. The control of dicumarol therapy and the quantitative determination of prothromibin and proconvertin. Scandinav. J. Clin. & Lab. Investigation 1951; 3: 201
   PubMed Web of Science ®Google Scholar
• Rehbein A., Jaretzki A., Habif D. V. The response of dicumarol-induced hypoprothrombinemia to vitamin K1. Ann. Surg. 1952; 135: 454
   PubMed Web of Science ®Google Scholar
• Russek H. I., Zohman B. L. An evaluation of anticoagulant therapy in the treatment of acute myocardial infarction. Am. Heart J. 1952; 43: 871
   PubMed Web of Science ®Google Scholar
• Van Buskirk W. C. The effect of intravenous injection of emulsified vitamin K1 on the hypoprothrombinemia induced by tromexan. New England J. Med. 1953; 248: 57
   PubMed Web of Science ®Google Scholar
• Van Itallie T. B., Geyer R. P., Stare F. J. The intravenous administration of emulsions of vitamin K1. J. Clin. Investigation 1951(a); 30: 680
   Web of Science ®Google Scholar
• Van Itallie T. B., Geyer R. P., Stare F. J. Vitamin K1 emulsions in bishydroxy-coumarin emergencies. Results of intravenous administration. J. A. M. A. 1951(b); 147: 1652
   PubMed Web of Science ®Google Scholar
• Watkin D. M., Van Itallie T. B., Logan W. B., Geyer R. P., Davidson C. S., Stare F. J. The treatment of dicumarol-induced hypopro-thrombinemia in man with emulsified vitamin K1 administered intravenously. J. Lab. & Clin. Med. 1951; 37: 269
   PubMed Web of Science ®Google Scholar
• Wright I. S., Beck D. F., Marple D. F. Myocardial infarction and its treatment with anticoagulants. Mod. Concepts Cardiovas. Dis. 1954; 23: 208
   PubMedGoogle Scholar
• Wright I. S., Marple C. D., Beck D. F. Report of the committee for the evaliation of anticoagulants in the treatment of coronary thrombosis with myocardial infarction. Am. Heart J. 1948; 36: 801
   PubMed Web of Science ®Google Scholar